Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

WANG Jing-guo, WANG Xiao-bo, XI Rong-gang, YAN Hong-sheng. The cost-effectiveness analysis of four programs treating primary hypertension[J]. Journal of Pharmaceutical Practice and Service, 2002, (2): 108-111.
Citation: WANG Jing-guo, WANG Xiao-bo, XI Rong-gang, YAN Hong-sheng. The cost-effectiveness analysis of four programs treating primary hypertension[J]. Journal of Pharmaceutical Practice and Service, 2002, (2): 108-111.

The cost-effectiveness analysis of four programs treating primary hypertension

  • Received Date: 2001-09-25
  • OBJECTIVE To investigate the economic effects produced by ACEI and calcium blocker treating the primary hypertension. METHODS The paper carries on a retrospective analytic valuation to the drugs-benezepril,perindopril,amlodipine and nit rendipine used by 232 cases of patients with primary hypertension and hold a comparison using the method of cost-effectiveness analysis.RESULTS Perindopril is the best drug low-ering blood pressures(regardless of systolic or diastolic blood pressure).CONCLUSION Through analysis we can come to the conclusion that pharmacoeconomics plays an important part in instructing reasonable utilization of drugs,controlling the rise of drug costs,lightening the economic burden of patients and raising the social eco-nomic results.Meanwhile,the studies of pharmacoeconomics is one of essential conditions and key measures to realize the reasonable distribution of health sources,and to safeguard the healthy movement of basic medical in-surance system and the instant perfection.It also has an important instructive function to develop the new drugs with high effect,few side effects and reasonable price.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2306) PDF downloads(643) Cited by()

Related
Proportional views

The cost-effectiveness analysis of four programs treating primary hypertension

Abstract: OBJECTIVE To investigate the economic effects produced by ACEI and calcium blocker treating the primary hypertension. METHODS The paper carries on a retrospective analytic valuation to the drugs-benezepril,perindopril,amlodipine and nit rendipine used by 232 cases of patients with primary hypertension and hold a comparison using the method of cost-effectiveness analysis.RESULTS Perindopril is the best drug low-ering blood pressures(regardless of systolic or diastolic blood pressure).CONCLUSION Through analysis we can come to the conclusion that pharmacoeconomics plays an important part in instructing reasonable utilization of drugs,controlling the rise of drug costs,lightening the economic burden of patients and raising the social eco-nomic results.Meanwhile,the studies of pharmacoeconomics is one of essential conditions and key measures to realize the reasonable distribution of health sources,and to safeguard the healthy movement of basic medical in-surance system and the instant perfection.It also has an important instructive function to develop the new drugs with high effect,few side effects and reasonable price.

WANG Jing-guo, WANG Xiao-bo, XI Rong-gang, YAN Hong-sheng. The cost-effectiveness analysis of four programs treating primary hypertension[J]. Journal of Pharmaceutical Practice and Service, 2002, (2): 108-111.
Citation: WANG Jing-guo, WANG Xiao-bo, XI Rong-gang, YAN Hong-sheng. The cost-effectiveness analysis of four programs treating primary hypertension[J]. Journal of Pharmaceutical Practice and Service, 2002, (2): 108-111.

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return